Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study

Arthritis Rheum. 2004 Mar;50(3):1005-7. doi: 10.1002/art.20195.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Female
  • Fibrosis
  • Humans
  • Immunoglobulins, Intravenous*
  • Male
  • Middle Aged
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / pathology*
  • Skin / pathology*
  • Time Factors
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous